ARCHIVED INSIGHTS
25 articlesRelated Company Shanghai Kehua Bio-Engineering Co.,Ltd.(002022.SZ) Interchina Holdings Co. Limited (HKG:0202) announced that it agreed to sell a maximum 854 million share at a price of HK$0.42 per share or HK$358.68 mill
Related Company Guangzhou Baiyunshan Pharmaceutical Co.,Ltd.(000522.SZ) Fairwood Holdings Limited (HKG:0052) bought back 41K shares at $12.50 per share, or a total of $512.5K on April 11 S8ource:chinesestock.org
Time Unit: Ton Jan-11 148,003.66 Feb-11 171,903.55 Mar-11 189,510.19 Apr-11 210,586.65 May-11 191,567.14 Jun-11 236,905.43 Jul-11 209,020.58 Aug-11 189,400.53 Sep-11 220,328.40 Oct-11 195,031.15 Nov-11 221,640.59 Dec-11
For the recent 20 years, China’s cancer patients have indicated the more youth citizens, higher incident rates and high mortality rates. Every minute, there are 6 patients been diagnosed as cancer patients. There are sev
Singapore, Feb 16, 2012: The international biotech and pharma community will converge upon the city of Suzhou, China, a rapidly growing base for life science industries, at ChinaBio Partnering Forum 2012 at the Kempinski
Singapore, Feb 16, 2012: Genetic Technologies received the Certificate of Compliance for its Australian laboratory under the US Clinical Laboratories Improvements Amendments (CLIA) regulations as administered by the Cent
Lotus Pharmaceuticals, Inc. (OTCBB: LTUS) ("Lotus" or the "Company"), a profitable developer, manufacturer and seller of medicine and drugs in the People's Republic of China ("PRC"), today announced it entered into an ag
Singapore, Feb 10, 2012: Australian vaccine development company BioDiem has licensed its live attenuated influenza virus (LAIV) vaccine technology to China-based Changchun BCHT Biotechnology (BCHT). This is an exclusive
Singapore, Feb 10, 2012: Integrated DNA technologies (IDT) has acquired the oligonucleotide business of Singapore’s top supplier in the field, 1st BASE. Already the world leader in custom nucleic acid synthesis, IDT will
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. ( HKG:8231 ) expected to record a substantial increase in profits for the year ended 31 December 2011 as compared to the profits in the year 2010. Such increase in p
Singapore, Feb 09, 2012: Roche and the Smithsonian Conservation Biology Institute in Washington, DC has announced collaboration agreement to use Roche’s GS Junior benchtop sequencing system for research in SCBI’s Center
Singapore, Feb 10, 2012: Takeda Pharmaceutical announced the establishment of the Takeda Shanghai Development Center (TSDC) within the Shanghai-based Takeda (China) Holdings (TCH), which is a wholly owned subsidiary of T
Singapore, Feb 10, 2012: In compliance with ASX Continuing Disclosure Rules, Genetic Technologies has executed a Settlement and License Agreement with Eurofins STA Laboratories of Longmont, Colorado, USA. Under the agree
BIOPHARMACEUTICAL company Bristol-Myers Squibb yesterday said it expected to double its China sales to 27 percent this year on strong demand for its key hepatitis and diabetes products. Last year, BMS's sales in China gr
CHINA will overtake US as the world's largest health products market by 2015, with the county's increasing demand for disease prevention, the China Chamber of Commerce for Import and Export of Medicines and Health Produc
Related Company Lijun International Pharmaceutical (Holding) Co. Ltd.(02005.HK) Results of Lijun International Pharmaceutical (HKG:2005) for the fiscal year ended 31 December 2011: Net loss: HK$41.377M (HK$260.689M net p
Related Company Wuyi International Pharmaceutical Company Limited(01889.HK) Results of Wuyi International Pharmaceutical Company (HKG:1889) for the fiscal year ended 31 December 2011: Net profit: RMB56.87M, down 46.32% Y
Related Company Venturepharm Laboratories Limited(08225.HK) Venturepharm Laboratories (HKG:8225) announced that, as more time is required to finalise the results for the year ended 31 December 2011, its board of director
Recently, reporters got news that apart from GAC Honda, Dongfeng Honda will also join Acura’s manufacturer team in China with relevant teams already established. Zhu Linjie, spokesman for Honda China, said he didn’t know
Taking advantage of the central government's latest policy to encourage the development of clean-energy vehicles, Chinese e-bike producers have grown rapidly in recent years. Brands such as AIMA, Luyuan and Yadea have be
China National Development and Reform Commission (short for NDRC) has released regulation related to management of the construction of charging piles for alternative energy vehicles in Beijing. NDRC indicated that there
New Car Assessment Program in China (short for C-NCAP) has released result of the fourth round of NCAP recently. There are six new models gaining five-star rating which include the flagship Borui of Geely while the luxur
Despite the rocketing growth of electric vehicle ownership in China in the past two years, the lack of a matched boost in charging facilities and power supply have become a bottleneck restricting the future development o
Scan to add our research consultant